StockData
ImageneBio, Inc. logo

ImageneBio, Inc. (IMA) stock

IMANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$3.72−0.09 (-2.36%)

Close on Nov 11, 2026Market cap $42.23MP/E –Yield –

ImageneBio statistics

61 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
Mar 9, 2027 (estimated, before the open)
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 11, 2026

Valuation ratiosIndustry

Market Cap
$42.23M
$282.97M
Enterprise Value
-$84.37M
$154.96M
PB Ratio
0.33
2.17
P/TBV Ratio
0.33
2.39

Share statisticsIndustry

Shares Change (YoY)
-18.7%
10.9%
Float
5M
49M
Shares Held by Insiders
52.9%
11.6%
Shares Held by Institutions
54.9%
56.4%

Short sellingIndustry

Short Interest
45,958
–
Short Interest Change
-25.1%
-0.76%
Short % of Float
0.86%
9.06%
Short % of Shares Outstanding
0.40%
6.38%
Days to Cover
3.96
5.16

Stock price statisticsIndustry

52-Week High
$8.84
–
52-Week Low
$3.60
–
20-Day Moving Average
$4.05
–
50-Day Moving Average
$4.45
–
200-Day Moving Average
$5.51
–
Average True Range (14)
$0.25
–
Price Change (1 Week)
-9.27%
-0.50%
Price Change (1 Month)
-12.3%
-0.33%
Price Change (3 Months)
-36.6%
-17.2%
Price Change (6 Months)
-35.5%
-20.1%
Price Change (YTD)
-46.1%
-20.1%
Price Change (1 Year)
-54.6%
-19.3%
Price Change (3 Years)
-78.8%
-23.4%
Price Change (5 Years)
-98.2%
-76.4%
Average Volume (10 Days)
8,983
–
Average Volume (20 Days)
11,595
–
Average Volume (90 Days)
12,786
–
Relative Volume
0.31
0.73
Relative Strength Index (14)
30.6
47.6
Volatility (1 Year)
56.9%
80.2%
Beta (5 Years)
1.17
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-32.3%
-51.3%
Return on Assets (ROA)
-28.6%
-40.3%
Return on Capital Employed (ROCE)
-37.2%
-37.7%

Financial positionIndustry

Current Ratio
16.17
3.30
Quick Ratio
15.68
2.37

GrowthIndustry

Revenue Growth (3Y CAGR)
-62.9%
2.25%
Revenue Growth (5Y CAGR)
-38.6%
6.41%

EfficiencyIndustry

Profits Per Employee
-$2.89M
-$680.86K
Employee Count
15
75
WACC
10.7%
10.1%

Income statement (TTM)Industry

Operating Income
-$50.08M
-$20.20M
Pretax Income
-$43.56M
-$13.50M
Net Income
-$43.33M
-$21.57M
EBITDA
-$49.68M
-$16.36M

Balance sheetIndustry

Net Cash (Debt)
$126.60M
$16.31M
Net Cash Per Share
$11.15
$0.70
Equity (Book Value)
$128.14M
$53.12M
Book Value Per Share
$11.29
$1.49
Tangible Book Value
$128.14M
$26.11M
Working Capital
$122.52M
$77.59M

Cash flow (TTM)Industry

Operating Cash Flow
-$40.61M
-$12.07M

Dividends and yieldsIndustry

Earnings Yield
-102.6%
-19.8%

Taxes and interestIndustry

Income Tax
-$230.00K
$79.50K

Scores and fair valueIndustry

Altman Z-Score
-0.99
0.28
Piotroski F-Score
5
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodIMAS&P 500DifferenceIMA per yearS&P 500 per year
1 month-12.3%-2.4%−9.9 pts
3 months-33.7%-1.2%−32.5 pts
Year to date-46.1%+12.3%−58.4 pts
1 year-56.8%+12.4%−69.2 pts
3 years-78.8%+78.8%−157.6 pts-40.3%+21.4%
5 years-98.1%+75.2%−173.3 pts-54.7%+11.9%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M IMA shares were sold short on Oct 30, 2026, down 25.1% from the previous report, or 0.86% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 39.4% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202645,958-25.1%11,6134.0
Oct 15, 202661,349+86.7%14,6384.2
Sep 30, 202632,852-5.1%17,2991.9
Sep 15, 202634,601-12.2%15,0472.3
Aug 31, 202639,412-20.1%11,7043.4
Aug 14, 202649,297-87.2%9,9565.0
Jul 31, 2026384,525-2.3%12,99129.6
Jul 15, 2026393,691-2.6%6,66459.1
Jun 30, 2026404,370+2.1%12,82631.5
Jun 15, 2026395,934-11.1%16,41624.1
May 29, 2026445,327+0.1%15,67728.4
May 15, 2026445,009-5.4%69,3146.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?